CollPlant closes $3.7 million private placement
CLGN•CollPlant Biotechnologies closed a private placement expected to generate approximately $3.7 million in gross proceeds. The offering included 989,301 ordinary shares or pre-funded warrants, along with warrants to purchase up to 1,483,950 shares.
1. Offering details
The offering closed on October 14, 2026. The combined purchase price was $3.74 per ordinary share with accompanying warrants, or $3.7499 per pre-funded warrant with accompanying warrants. The ordinary warrants have a $3.74 exercise price and expire five years after the registration statement becomes effective. Net proceeds will support general corporate purposes, including working capital and research and development programs.
